InsiderClue
Insiders · Profile

Turtle Cameron

Chief Executive Officer at Spyre Therapeutics · See Remarks at BridgeBio Pharma. Filing since 8 Jan 2020. CIK 0001758363

SYRE Spyre Therapeutics, Inc. Chief Executive Officer · 12 trades BBIO BridgeBio Pharma, Inc. See Remarks · 13 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE Spyre Therapeutics, Inc.
1 Oct 2026
Chief Executive Officer
Sold on a plan
15,000
$1.38M
2.7%
SYRE Spyre Therapeutics, Inc.
1 Sep 2026
Chief Executive Officer
Sold on a plan
15,000
$1.31M
2.6%
SYRE Spyre Therapeutics, Inc.
3 Aug 2026
Chief Executive Officer
Sold on a plan
15,000
$1.43M
2.6%
SYRE Spyre Therapeutics, Inc.
1 Jul 2026
Chief Executive Officer
Sold on a plan
15,000
$1.32M
2.5%
SYRE Spyre Therapeutics, Inc.
1 Jun 2026
Chief Executive Officer
Sold on a plan
15,000
$1.06M
2.4%
SYRE Spyre Therapeutics, Inc.
1 May 2026
Chief Executive Officer
Sold on a plan
15,000
$1.07M
2.4%
SYRE Spyre Therapeutics, Inc.
1 Apr 2026
Chief Executive Officer
Sold on a plan
15,000
$739.91K
2.3%
SYRE Spyre Therapeutics, Inc.
2 Mar 2026
Chief Executive Officer
Sold on a plan
15,000
$632.87K
2.3%
SYRE Spyre Therapeutics, Inc.
2 Feb 2026
Chief Executive Officer
Sold on a plan
15,000
$492.05K
2.2%
SYRE Spyre Therapeutics, Inc.
2 Jan 2026
Chief Executive Officer
Sold on a plan
15,000
$460.13K
2.2%
SYRE Spyre Therapeutics, Inc.
1 Dec 2025
Chief Executive Officer
Sold on a plan
15,000
$435.36K
2.1%
SYRE Spyre Therapeutics, Inc.
3 Nov 2025
Chief Executive Officer
Sold on a plan
45,000
$1.05M
6.0%
BBIO BridgeBio Pharma, Inc.
28 Dec 2020
See Remarks
Sold, plan not stated
19,500
$1.36M
60.8%
BBIO BridgeBio Pharma, Inc.
25 Nov 2020
See Remarks
Sold, plan not stated
742
$35.04K
5.6%
BBIO BridgeBio Pharma, Inc.
24 Nov 2020
See Remarks
Sold, plan not stated
4,258
$200.14K
25.3%
BBIO BridgeBio Pharma, Inc.
5 Nov 2020
See Remarks
Sold, plan not stated
2,500
$105.12K
16.6%
BBIO BridgeBio Pharma, Inc.
30 Sep 2020
See Remarks
Sold, plan not stated
14,500
$546.46K
53.6%
BBIO BridgeBio Pharma, Inc.
18 Sep 2020
See Remarks
Sold, plan not stated
2,500
$105.02K
16.6%
BBIO BridgeBio Pharma, Inc.
15 Sep 2020
See Remarks
Sold, plan not stated
2,500
$92.65K
16.6%
BBIO BridgeBio Pharma, Inc.
11 Sep 2020
See Remarks
Sold, plan not stated
2,000
$70.05K
13.7%
BBIO BridgeBio Pharma, Inc.
30 Jun 2020
See Remarks
Sold, plan not stated
10,000
$326.62K
50.4%
BBIO BridgeBio Pharma, Inc.
27 Apr 2020
See Remarks
Sold, plan not stated
2,000
$64.03K
16.9%
BBIO BridgeBio Pharma, Inc.
8 Apr 2020
See Remarks
Sold, plan not stated
8,000
$216.36K
44.9%
BBIO BridgeBio Pharma, Inc.
11 Feb 2020
See Remarks
Sold, plan not stated
2,000
$74.56K
16.9%
BBIO BridgeBio Pharma, Inc.
8 Jan 2020
See Remarks
Sold, plan not stated
12,807
$440.21K
56.6%
25 decisions on file.